Literature DB >> 11832731

Intermediate term failure of pubovaginal slings using cadaveric fascia lata: a case series.

Keith J O'Reilly1, Fred E Govier.   

Abstract

PURPOSE: The pubovaginal sling procedure using autologous fascia has become the gold standard for treating intrinsic sphincter deficiency and stress urinary incontinence in women. A recent modification has been the use of cadaveric fascia as the sling material. We recently reported similar results for cadaveric fascia lata in 121 women and autologous fascia lata in 46 at a mean followup of 12 months. We have now identified 8 patients who experienced intermediate term failure at 4 to 13 months using cadaveric fascia lata.
MATERIALS AND METHODS: We retrospectively reviewed the records of 8 of 121 patients who received a pubovaginal sling using cadaveric fascia lata between February 1997 and June 1999 and had recurrent stress incontinence after 4 to 13 months. We reviewed the type of fascia, surgical technique, preoperative and postoperative urodynamics, surgical history and medical co-morbidities.
RESULTS: We identified 8 patients who underwent a pubovaginal sling using cadaveric fascia lata and had recurrent stress urinary incontinence at a mean of 6.5 months (range 4 to 13) after the procedure. Fresh frozen fascia from a local tissue bank was used and the surgical technique was identical in all cases. Postoperatively urodynamics confirmed recurrent intrinsic sphincter deficiency. Previous incontinence surgery had been done in 7 of the 8 patients. Patient co-morbidities included neurological disease, diabetes mellitus, previous pelvic irradiation and previous pelvic surgery.
CONCLUSIONS: We identified a higher than expected intermediate term failure rate using fresh frozen cadaveric fascia lata. This risk must be weighed against the advantages of decreased operative time and patient morbidity. Longer followup and larger numbers are necessary to determine how much of a problem exists and what patient characteristics are relevant when selecting cadaveric grafts.

Entities:  

Mesh:

Year:  2002        PMID: 11832731     DOI: 10.1097/00005392-200203000-00034

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Advances toward tissue engineering for the treatment of stress urinary incontinence.

Authors:  Ron Jankowski; Ryan Pruchnic; Michael Hiles; Michael B Chancellor
Journal:  Rev Urol       Date:  2004

2.  Medium-term follow-up on use of freeze-dried, irradiated donor fascia for sacrocolpopexy and sling procedures.

Authors:  Mary Pat FitzGerald; S Renee Edwards; Dee Fenner
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004 Jul-Aug

3.  Biomaterials in urinary incontinence and treatment of their complications.

Authors:  Philippa Sangster; Roland Morley
Journal:  Indian J Urol       Date:  2010-04

4.  Bovine dermis: a novel biologic substitute for autologous tissue in sling surgery.

Authors:  Christopher M Wilson; B Jill Williams; Seth Bilello; Alex Gomelsky
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-08-09

5.  Transvaginal bone-anchored sling for the treatment of female stress urinary incontinence: effect of Valsalva leak point pressure and prior pelvic surgery on outcomes.

Authors:  David E Rapp; Tanya M Nazemi; Kathleen C Kobashi; Fred E Govier
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-05-09

6.  Factors that affect recurrence after anterior colporrhaphy procedure reinforced with four-corner anchored polypropylene mesh.

Authors:  M J Hung; F S Liu; P S Shen; G D Chen; L Y Lin; E S C Ho
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-06-02

Review 7.  The use of graft materials in anterior compartment pelvic reconstruction.

Authors:  J Sean Begley; Kathleen C Kobashi
Journal:  Curr Urol Rep       Date:  2004-10       Impact factor: 2.862

Review 8.  Current Treatments for Female Pelvic Floor Dysfunctions.

Authors:  Mun-Kun Hong; Dah-Ching Ding
Journal:  Gynecol Minim Invasive Ther       Date:  2019-10-24

Review 9.  Sling failures: what's next?

Authors:  Harriette M Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2004-10       Impact factor: 2.862

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.